Abstract:Background: Currently, chromosomal microarray analysis is considered the first-tier test in pediatric care and prenatal diagnosis. However, the diagnostic yield of chromosomal microarray analysis for prenatal diagnosis of congenital heart disease has not been evaluated based on a large cohort. Objective: Our aim was to evaluate the clinical utility of chromosomal microarray as the first-tier test for chromosomal abnormalities in fetuses with congenital heart disease. Study design: In this prospective study, 602 prenatal cases of congenital heart disease were investigated using single nucleotide polymorphism array over a 5-year period. Results: Overall, pathogenic chromosomal abnormalities were identified in 125 (20.8%) of 602 prenatal cases of congenital heart disease, with 52.0% of them being numerical chromosomal abnormalities. The detection rates of likely pathogenic copy number variations and variants of uncertain significance were 1.3% and 6.0%, respectively. The detection rate of pathogenic chromosomal abnormalities in congenital heart disease plus additional structural anomalies (48.9% vs 14.3%, P < .0001) or intrauterine growth retardation group (50.0% vs 14.3%, P = .044) was significantly higher than that in isolated congenital heart disease group. Additionally, the detection rate in congenital heart disease with additional structural anomalies group was significantly higher than that in congenital heart disease with soft markers group (48.9% vs 19.8%, P < .0001). No significant difference was observed in the detection rates between congenital heart disease with additional structural anomalies and congenital heart disease with intrauterine growth retardation groups (48.9% vs 50.0%), congenital heart disease with soft markers and congenital heart disease with intrauterine growth retardation groups (19.8% vs 50.0%), or congenital heart disease with soft markers and isolated congenital heart disease groups (19.8% vs 14.3%). The detection rate in fetuses with congenital heart disease plus mild ventriculomegaly was significantly higher than in those with other types of soft markers (50.0% vs 15.6%, P < .05). Conclusion: Our study suggests chromosomal microarray analysis is a reliable and high-resolution technology and should be used as the first-tier test for prenatal diagnosis of congenital heart disease in clinical practice.

Prenatal Genetic Diagnosis in Three Fetuses With Left Heart Hypoplasia (LHH) From Three Unrelated Families

The contribution of single-gene defects to congenital cardiac left-sided lesions in the prenatal setting.

Prenatal detection of novel compound heterozygous variants of the PLD1 gene in a fetus with congenital heart disease

Fetal Congenital Heart Disease Caused by Compound Heterozygous Mutations in the DNAH9 Gene: A Case Report

[Prenatal Genetic Study of Fetuses with Congenital Heart Diseases].

Case Report: Prenatal Diagnosis of Fetal Intracranial Hemorrhage Due to Compound Mutations in the JAM3 Gene

A HAND2 Loss-of-Function Mutation Causes Familial Ventricular Septal Defect and Pulmonary Stenosis

Prenatal genetic diagnosis of fetuses with dextrocardia using whole exome sequencing in a tertiary center

Prenatal Trio-Based Whole Exome Sequencing in Fetuses with Abnormalities of the Skeletal System

Genomic insights into prenatal diagnosis of congenital heart defects: value of CNV-seq and WES in clinical practice

[Whole Exome Sequencing Analysis of 37 Fetuses with Cardiac Abnormalities].

KLF13 Loss-of-function Variation Contributes to Familial Congenital Heart Defects

Whole-exome sequencing of pathogenic genes in a family with congenital heart disease: A case report

Genetic Architecture in Neonatal Intensive Care Unit Patients with Congenital Heart Defects: a Retrospective Study from the China Neonatal Genomes Project.

Prenatal chromosomal microarray analysis in a large Chinese cohort of fetuses with congenital heart defects: a single center study

Diagnostic Yield of Whole Exome Data in Fetuses Aborted for Conotruncal Malformations

Prenatal diagnosis of fetuses with ultrasound anomalies by whole-exome sequencing in Luoyang city, China

Prenatal chromosomal microarray analysis in fetuses with congenital heart disease: a prospective cohort study

ENU-based dominant genetic screen identifies contractile and neuronal gene mutations in congenital heart disease

Prenatal diagnosis in the fetal hyperechogenic kidneys: assessment using chromosomal microarray analysis and exome sequencing

Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation